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1 PREDICTION OF THE OUTCOMES FOLLOWING LIVER
TRANSPLANTATION FOR HEPATOCELLULAR CANCER
Aldouri AQ1, Almukhtar A1, White S1, Toogood G1, Pollard S1,
Lodge JPA1, Wyatt J2, Prasad KR1, (1) HPB and Transplant
Unit; (2) Department of Pathology, St James’s University Hospital,
Leeds, UK
INTRODUCTION AND AIM: Hepatocellular carcinoma (HCC)
is a well-established indication for orthotopic liver transplantation
(OLT). Patient selection is often based on Milan criteria (Mazzaferro
et al., 1996). Since then other centres have reported their experience,
which questioned the usefulness of the Milan criteria, and they
proposed their own selection guidelines. The aim of this study was to
report the experience of 81 consecutive patients undergoing OLT for
HCC and to analyse the outcome based on different criteria. These
included Milan, UCSF and the Pittsburgh modified TNM criteria.
PATIENTS AND METHODS: Between 1995 and 2002, 852 OLT
were performed; 81 patients (9.5%) underwent OLT for HCC.
Preoperatively patients were assessed by imaging, to evaluate the
number, size and presence of vascular invasion. The explanted
specimens were histologically evaluated in terms of size, number,
distribution, pathological grade and vascular invasion. Survival
analysis was performed using Kaplan-Meier and Cox proportional
hazards regression methods. RESULTS: There was no significant
difference in 5-year survival rates between patients with HCC
exceeding Milan criteria (n=30) versus those meeting Milan criteria
(n=51), 52% vs 58.6% respectively. In comparison 5-year sur-
vival according to the UCSF criteria (n=59) was 59% vs 47% for
those outside UCSF criteria (n=22) (p=0.7). However, patients
with stage I and II Pittsburgh criteria had significantly higher
5-year survival compared with patients with stage III and IV disease
(69% vs 34%; p50.02). CONCLUSION: This study demonstrates
that the Pittsburgh modified TNM criteria are a more useful
predictor of long-term survival for patients with HCC treated
by OLT.
2 TECHNICAL REFINEMENTS AND RESULTS IN
FULL-RIGHT FULL-LEFT SPLITTING OF THE CADAVERIC
DONOR LIVER
Broering DC1, Wilms C1, Lenk C1, Kim JS1, Fischer L1, Hillert C1,
Ganschow R2, Burdelski M2, Helmke K3, Rogiers X1, (1)
Department of Hepatobiliary Surgery and Visceral Transplantation,
University; (2) Department of Pediatrics; (3) Department of
Pediatric Radiology, University Hospital Hamburg-Eppendorf,
Hamburg, Germany
INTRODUCTION AND AIM: Splitting of the liver along the line of
Cantilie is an established technique for the adult living donor
procedure. The same procedure is still considered as experimental
and even controversial, when performed in the cadaveric donor, as
most liver transplantation surgeons refuse to perform full-right full-
left splitting. The aim of this study is to illustrate the technical
evolution and the results of this new procedure in our institution.
PATIENTS AND METHODS: From 1/1999 to 8/2004 a total of 35
FRFL split-liver transplantations (16 right grafts=FR (Seg. V–VIII)
and 19 left grafts=FL (Seg. I–IV) were performed in our centre.
Seven splits were performed in situ, and 12 splits ex situ. Splitting of
the vena cava was applied in 18 splits and additional splitting of the
middle hepatic vein in 8. Seven adults and 12 adolescents received
the FL grafts. Recipients of FR grafts were exclusively adults. The
outcome of these 35 recipients of full-right full-left split liver grafts
was prospectively evaluated. RESULTS: Four patients died (actual
patient survival FR group: 87.5% vs FL group: 89.5%), three due to
septic MOF and one due to graft versus host disease. In each of both
groups two recipients had to undergo retransplantation (actual graft
survival FR group: 75% vs FL group: 78.9%), the cause of which was
PNF (FL group: n=2), chronic graft dysfunction (FR group: n=1)
and in one case recurrence of PSC (FR group: n=1). PPF was
observed in one case (FR group: n=1). Biliary complications
occurred in the FR and FL groups in 37.5% (FR group: n=6) and
21% (FL group: n=4). Postoperative bleeding occurred in one
case (FR group). Arterial, portal and venous complications were
not observed in either group. CONCLUSION: The technical
development of full-right full-left splitting has evolved to the point of
allowing excellent results. The major remaining challenge is the
reduction of biliary complications. The key to success is the choice of
a suitable recipient for the corresponding graft. Full-right full-left
splitting has reached adulthood and deserves to be considered as a
reasonable instrument to reduce the need for living donation.
3 THE FIRST TWO CASES OF LIVING DONOR LIVER
TRANSPLANTATION USING DUAL GRAFTS IN THE
WESTERN WORLD
Walter J, Fischer L, Hillert C, Wilms C, Mueller L, Rogiers X,
Broering DC, Department of Hepatobiliary Surgery and
Transplantation, University Hospital Hamburg-Eppendorf,
Hamburg, Germany
INTRODUCTION AND AIM: The major limitation of adult-
to-adult living donor liver transplantation (LDLT) is the high
failure rate of the donors. Only 20% of the potential donors are
suitable to donate the right liver, due to a insufficient remnant liver
volume in the donor. Alternatively, dual grafts from 2 living donors
can be implanted in 1 recipient, solving the problem of graft size
insufficiency by securing the donor’s safety. PATIENTS AND
METHODS: We report the first 2 cases of adult-to-adult LDLT
using dual grafts in the western world, successfully performed in our
institution. Recipient 1 suffered from hepatitis C cirrhosis, recipient
2 from hepatitis B cirrhosis. Single right lobe donation was impos-
sible, in case 1 due to insufficient donor’s remnant liver volume
(530%), in case 2 due to insufficient recipient’s graft volume
(GRWR 50.7%). Dual grafts were used, in case 1 a left lateral
and a full left lobe, in case 2 a full right and a left lateral lobe.
RESULTS: Operation times were 17 and 13 h. Technically complex
reconstructions with 11 anastomoses were performed. Both dual
grafts were functioning well. The postoperative course was unevent-
ful in both recipients and all four donors. CONCLUSION: While the
shortage of donors is increasing, LDLT using dual grafts represents
an elegant innovative procedure to allow liver transplantation in
situations of insufficient remnant liver volume in the donor or
insufficient graft volume for the recipient. Safety of the donor is
secured while avoiding right lobectomy with a critical remaining liver
volume (30–35%).
4 IS IL-6 PLASMA CONCENTRATION PREDICTIVE
FOR THE OUTCOME OF LIVER TRANSPLANTATION?
Trunecka P4, Wohl P1, Lanska V2, Kieslichova E3, Spicak J4, Striz I5,
(1) Department of Diabetes; (2) Department of Statistics;
(3) Department of Anesteziology; (4) Department of
Hepatogastroenterology; (5) Department of Immunology, IKEM,
Institute for Clinical and Experimental Medicine, Prague 4,
Czech Republic
INTRODUCTION AND AIM: IL-6 is necessary for the induction
of liver regeneration in vivo. High IL-6 plasma levels after liver
resection correlate with beneficial clinical outcome. A prospective
study to evaluate predictive value of pretransplantation IL-6 plasma
concentration for the outcome of liver transplantation was under-
taken. PATIENTS AND METHODS: Material and IL-6 (ELISA,
R&D Systems, Abingdon, UK) were measured during pretransplant
evaluation and immediately before transplantation in 68 liver trans-
plant candidates with chronic liver disease transplanted in our center
from 11/2001 until 8/2003. Nutritional status evaluation using
anthropometry, dual-energy X-ray absorptiometry, indirect calori-
metry, biochemical profile, and HGF plasma concentration were
performed. RESULTS: Seven patients died, all early after surgery.
1-year patient and graft survival were 89% and 86%, respectively.
The mean pretransplant IL-6 plasma concentration was 8.55
(+1.76) pg/ml in group of deceased and 20.5 (+40.5) pg/ml among
recipients surviving 6 months after transplantation (p50.04). No
parameters of energy metabolism, nor body composition, were
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predictive for higher resource utilization except BMI for longer
ICU and total hospital stay (p50.05). Factors predictive for above
median blood products replacement were MELD score (p=0.013),
Child Pugh score (p=0.006), ICG retention (p=0.02), number
connection test (p50.016). CONCLUSION: Higher IL-6 plasma
levels may play a positive role during the peritransplantation period.
Our results prompt further investigation of its possible role in the
setting of liver transplantation. Extensive nutritional assessment
brought little information to predict the outcome of transplantation.
5 INITIAL RESULTS OF THE “FULL-SPLIT” TECHNIQUE
Kim JS1, Mueller T1, Grotelueschen R1, Fischer L1, Ganschow R2,
Helmke K2, Burdelski M2, Rogiers X1, Broering D1, (1) Department
of Hepatobiliary Surgery and Multiorgan Transplantation,
University Hospital Eppendorf; (2) Department of Pediatrics,
University Hospital Eppendorf, Hamburg, Germany
INTRODUCTION AND AIM: To overcome the shortage of size-
matched donor organs for adolescent patients with end-stage liver
disease, the ‘full-split’ technique was introduced. The outcome of 14
full left lobe donations was retrospectively analysed to evaluate the
feasibility of this procedure. PATIENTS AND METHODS: From
May 2001 until September 2004, 170 consecutive pediatric liver
transplantations were performed at our center. During this time
period, 14 full left lobes (segments I–IV) were transplanted; 11 split
(79%) and 3 living donor (21%) liver transplantations. 10 were
primary, 3 secondary and 1 third liver transplantations. 29% of the
recipients were on a high urgent status. RESULTS: After 14 full left
lobe donations no patient died within the hospital course (3-month
patient survival of 100%). During further follow-up, one child died
due to recurrence of malignancy 1 year after transplantation (actual
patient survival 93%). One patient developed PNF on the 5th post-
operative day and had to undergo retransplantation. The actual graft
survival is 86%. Biliary complication rate was 14% and one patient
(7%) was reoperated due to postoperative bleeding on the cut
surface. CONCLUSION: Patient and graft survival after full left
lobe donation does not significantly differ from the nowadays stan-
dardized left lateral donation (segments II and III) for smaller infants.
The full left lobe provides adolescent recipients with optimal size
matching grafts without affecting the adult donor organ pool and is a
safe and feasible procedure.
6 INCIDENCE AND MANAGEMENT OF EARLY AND
LATE BILIARY COMPLICATIONS AFTER PEDIATRIC
LIVER TRANSPLANTATION
Kim JS1, Mueller T1, Grotelueschen R1, Fischer L1, Ganschow R2,
Helmke K2, Burdelski M2, Rogiers X1, Broering D1, (1) Department
of Hepatobiliary Surgery and Multiorgan Transplantation;
(2) Deparment of Pediatrics, University Hospital Eppendorf,
Hamburg, Germany
INTRODUCTION AND AIM: A series of 374 consecutive pedia-
tric liver transplantations using all techniques was retrospectively
analysed to evaluate biliary complications and analyse methods of
treatment. PATIENTS AND METHODS: From January 1995 until
September 2004, 59 whole organs (15.8%), 41 reduced-size
(12.6%), 165 split organs (44.1%) and 109 from living donors (29%)
were performed; 311 (83.2%) were primary, 54 (14.4%) secondary,
8 (2%) third and 1 (0.3%) fourth OLT. The biliary tract was
reconstructed using Roux-en-Y choledochojejunostomy, in a few
cases using an end-to-end anastomosis without placing stents.
RESULTS: After 374 pediatric OLTs, biliary tract complications
occurred in 45 cases (12%). Bile leaks that occurred in 25 cases
(6.7%) were the most frequent complications. 14 bile leaks were
located at the Roux-en-Y choledochojejunostomy and in 7 cases a
reconstruction was necessary. 11 bile leaks were located on the cut
surface. The rate of bile leaks after split and living donor liver
transplantations was 7.3% and 6.9%, respectively. Bile duct
strictures occurred in 20 cases (5.3%). In 12 cases the Roux-en-Y
choledochojejunostomy was redone, in 8 cases a percutaneous
transhepatic drainage was placed. The rate of bile duct strictures after
split and living donor liver transplantation was 6% and 4.7%,
respectively. CONCLUSION: Biliary complication rate after
pediatric split and living donor liver transplantation showed no
significant difference. Endoscopic and percutaneous transhepatic
radiologic procedures are complementary and effective treatments
for pediatric patients with biliary complications, although surgical
intervention is still obligatory in selected cases. Biliary complications
are not associated with significant mortality and graft loss.
7 PRESERVATION OF THE NON-HEART-BEATING
DONOR LIVER BYMACHINE PERFUSION USING POLYSOL,
A NEW PERFUSION SOLUTION
Bessems M, Doorschodt B, van Vliet A, van Gulik T, Surgical
Laboratory, Department of Surgery, Academic Medical Center,
Amsterdam, Netherlands
INTRODUCTION AND AIM: Interest in the use of non-heart-
beating donor organs (NHBD) is increasing. In order for post-
transplant graft function, these organs need optimal preservation.
Literature has shown advantages of hypothermic machine perfusion
(MP) over cold storage (CS). The modified University of Wisconsin
solution (UW-G) is used as an MP preservation solution. However,
this solution may cause microvasculatory obstructions, is difficult to
obtain and expensive. We have therefore developed Polysol, an
enriched preservation solution containing specific nutrients. The aim
of this study was to compare Polysol with UW-G for MP.
PATIENTS AND METHODS: In an isolated perfused NHBD rat
liver model 24-h hypothermic MP using UW-G was compared to MP
using Polysol. To determine liver parenchymal damage ALT and
LDH levels were measured during 60 min reperfusion with Krebs-
Henseleit buffer. Liver function was measured by bile production
and ammonia clearance. Control livers were reperfused after CS in
regular UW. RESULTS: Liver damage was higher in the control
group compared to MP using UW-G or Polysol. MP using Polysol as
compared to UW-G did not result in less liver damage. Flow at
reperfusion was higher when using Polysol as compared to UW-G.
Bile production and ammonia clearance were higher when using
Polysol as compared to UW-G. There was less cellular edema after
preservation with Polysol as compared to UW-G and control.
CONCLUSION: Machine perfusion of NHBD livers using UW-G
or Polysol results in less hepatocellular damage than cold storage
using UW. Machine perfusion of rat livers using Polysol is superior to
machine perfusion using UW-G.
8 COMPARISON BETWEEN NORMOTHERMIC (37C)
AND SUBNORMOTHERMIC (15C) TRANSPORT
TEMPERATURES IN THE AMC BIOARTIFICIAL LIVER
(AMC-BAL)
Poyck PPC3, Hoekstra R1, Chamuleau RAFM2, Van Gulik TM3,
(1) AMC Liver Center, Academic Medical Center; (2) Dept.
Hepatology; Academic Medical Center; (3) Surgery (Surgical
Laboratory), Academic Medical Centre, Amsterdam, The
Netherlands
INTRODUCTION AND AIM: The conditions of porcine hepato-
cyte preservation during transport of a bioartificial liver (BAL) from
the laboratory to the hospital play a crucial role in the liver supporting
capacity of the BAL. Previous experiments showed that liver specific
functions are well-preserved in 2-D cultures during 24 h at
temperatures as low as 15C. This study addresses the question
whether this was also applicable to the AMC-BAL based on its 3-D
organization of hepatocyte aggregates and direct contact between
cells and perfusion medium. PATIENTS AND METHODS: Two
laboratory-scale AMC bioreactors were loaded with one billion
freshly isolated porcine hepatocytes per experiment (n=6). Bio-
reactors in the control group were cultured for 3 days at 37C. In
parallel, bioreactors in the transport group were cultured at 15C for
24 h at day 2, and cultured at 37C at days 1 and 3. All bioreactors
were tested each day simultaneously at 37C for cell damage (LDH
and AST release), hepatic function (ammonia and lidocaine clear-
ance, urea and albumin synthesis) and metabolic activity (oxygen and
glucose consumption, and lactate production). RESULTS: Both
groups performed equally at day 1 for all parameters. In the transport
group, all hepatic functions were not reduced at day 2 and 3 as
compared to the control group. Only LDH release at day 2 was
significantly higher than the control group. Glucose consumption
and lactate production was significantly lower than the control group.
CONCLUSION: Transport of the AMC-BAL charged with primary
porcine hepatocytes for 24 h at 15C does not impair liver-specific
function.
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9 INCIDENCE AND CAUSE OF ALLOGRAFT STEATOSIS
AFTER LIVER TRANSPLANTATION. A PROTOCOL
BIOPSY-BASED STUDY
Culkova E1, Trunecka P1, Honsova E2, Skibova J3, Hucl T1,
Adamec M4, Spicak J1, (1) Department of Hepatology;
(2) Department of Pathology, Medicine; (3) Department of
Biostatistics; (4) Department of Transplantation Surgery, Institute
for Clinical and Experimental Medicine, Prague 4, Czech Republic
INTRODUCTION AND AIM: Liver steatosis is a frequent finding
in patients after liver transplantation (LTx). The frequency and
relationship of allograft steatosis to primary liver disease has not been
determined yet. The aim of our study was to determine the rela-
tionship of allograft steatosis to primary liver disease and to various
clinical and biochemical parameters after LTx. PATIENTS AND
METHODS: Three hundred patients who underwent liver trans-
plantation in our center between 1995 and 2003 and were followed
for at least 1 year were retrospectively analyzed. Clinical and
biochemical parameters of patients who presented with allograft
steatosis430% on protocol biopsies were compared to age, sex and
time interval from LTx matched controls. Statistical analysis was
performed using the chi-squared test, t-test and Mann-Whitney test.
RESULTS: Allograft steatosis was found in 57 patients (19%) at a
mean time of 37 months after LTx. Patients with steatosis underwent
LTx more frequently for alcoholic cirrhosis (49% vs 24%, p50.05)
and less frequently for cholestatic liver diseases (10% vs 26%,
p50.05). Of 28 recipients transplanted for alcoholic cirrhosis, 10 had
recurrence of alcohol abuse. The steatosis group had significantly
higher levels of plasma triglycerides (p50.001) and liver function
tests (p50.01). There were significantly more patients with hyper-
glycemia in the steatosis group (p50.01). Body weight, blood pres-
sure and immunosuppression regimen after LTx were not associated
with incidence of allograft steatosis. CONCLUSION: Most cases of
allograft steatosis could be attributed to alcoholic liver disease
recurrence, only a smaller proportion seems to be a part of the
metabolic syndrome.
10 VOLUMETRIC ASSESSMENT OF DONOR LIVER
AFTER HARVESTING LEFT LOBE FOR LIVING RELATED
LIVER TRANSPLANTATION
Paluszkiewicz R1, Hevelke P1, Zieniewicz K1, Pacho R2, Grzelak I1,
Lechowicz R1, Krawczyk M1, (1) Department of General & Liver
Surgery; (2) Department of Radiology, Medical University of
Warsaw, Warsaw, Poland
INTRODUCTION AND AIM: CT-assisted volumetry permits
estimatation of the volume of the graft, as well as monitoring of the
donor’s liver regeneration. The aim of the study was the observation
of restitution of liver tissue in donors after harvesting of the
liver fragment for living-related liver transplantation (LRLT).
PATIENTS AND METHODS: In 64 living related liver donors the
size of the whole liver and of segments II, III, IV was assessed by
preoperative computerized abdominal tomography (CT) volumetry.
Segments II and III were harvested in 56 cases; segments II, III and
IV in 8 cases.The remnant liver was assessed by CT volumetry on the
7th, 30th and on the 180th post-operation day. RESULTS: The
correlation between the calculated volume of the graft and its weight
was linear (R=0.56, p50.04). Postoperative CT volumetry of the
liver of living-related donors showed a different pattern of volume
restoration (regeneration index) after both 7 and after 30 days, in
donors who sacrificed segments II and III in comparison with those
who sacrificed segments II, III and IV. The mean regeneration
indexes were significantly higher in donors of segments II, III and IV
compared with donors of segments II and III after 7 and 30 days
(p50.05). 180 days after harvesting there was no difference between
regeneration indexes in donors of segments II, III, and IV and donors
of segments II and III (p40.05). CONCLUSION: It may be
speculated that the donor’s liver displays a different pattern of growth
due to the alternation in blood supply to segment IV.
11 FAS LIGAND EXPRESSION FOLLOWING
NORMOTHERMIC LIVER ISCHEMIA-REPERFUSION
Cursio R3, Filippa N1, Miele C2, Colosetti P1, Auberger P1, Van
Obberghen E1, Gugenheim J3, (1) INSERM U145, Universite´ de
Nice Sophia Antipolis, Nice, France; (2) Dipart. di Biologia e
Patologia Cellulare, CEOS and CNR, Universita` Federico II di
Napoli, Napoli, Italia; (3) France, Lab. de Recherches Chirurgicales,
Universite´ de Nice Sophia Antipolis, Nice, France
INTRODUCTION AND AIM: The aim of this study was to
evaluate the role of the pro-apoptotic molecule Fas ligand (FasL) in
120-min normothermic ischemia-reperfusion (I-R) induced apop-
tosis in rat liver treated or not with Z-Asp-cmk caspase inhibitor.
PATIENTS AND METHODS: Rats were divided into two
groups: group 1, control, PBS administration; group 2, Z-Asp-cmk
treatment. Z-Asp-cmk was injected intravenously, 2 min prior to
induction of 120 min of normothermic liver ischemia. Immuno-
histochemical detection of apoptotic liver cells was carried out using
the TUNEL method. Fas and FasL expression were measured
by qualitative reverse transcription polymerase chain reaction (RT-
PCR), Northern and Western blot, and by immunofluorescence
labeling, in ischemic and non-ischemic liver lobes at different times
after reperfusion. RESULTS: FasL mRNA and protein expression
were increased in ischemic liver, whilst Fas receptor mRNA levels
remained unchanged. Pre-treatment of rats with Z-Asp-cmk caspase
inhibitor reduced liver apoptosis, but did not modify FasL mRNA
levels. CONCLUSION: These results suggest that the pro-apoptotic
molecule FasL is involved in the induction of liver cell death
following I-R.
12 BILIARY COMPLICATION IN LIVING DONOR
LIVER TRANSPLANTATION USING RIGHT LOBE
Kim DG, Kim KW, Lee MD, Department of Surgery, Catholic
University of Korea, Seoul, Korea
INTRODUCTION AND AIM: Living donor liver transplantation
(LDLT) using right lobe provides enough graft mass for the recipient
and is a safe procedure for the donor. Biliary reconstruction remains a
main cause of morbidity in LDLT and the biliary complication could
cause cholangitis, sepsis and eventually retransplantation or death.
PATIENTS AND METHODS: From January to April 2004, 125
patients underwent LDLT using right lobe in the Department of
Surgery, Catholic University of Korea. Patients were 89 men and 36
women with a mean age of 49.3 years. We reviewed (1) biliary
anatomy and reconstruction method, (2) biliary complication and
contributing factors. RESULTS: According to Couinaud classifica-
tion on biliary anatomy, type 1 is the most common type (68.8%).
The reconstruction method depended on anatomical type and
number of lumen but most of the cases were reconstructed end-to-
end anastomosis fashion, single or double after ductoplasty in case of
multiple lumens. The biliary complications consisted of leakage
(15.2%) and stricture (15.2%) and the complications were directly
correlated to the biliary anatomy. Treatment of leakage comprised
percutaneous drainage or conservative treatment with spontaneous
healing and in cases of stricture, the most common procedures were
PTBD or balloon dilatation. CONCLUSION: Duct-to-duct
anastomosis can be performed in the majority of patients and it is
important to define the better plan of transection on biliary tree to
obtain one lumen of biliary tract, which could reduce biliary
complications.
13 ACTUAL NON-ESTIMATED 10-YEAR SURVIVAL IN
ADULTS AFTER LIVER TRANSPLANTATION (LT)
van der Hilst CS3, IJtsma AJC1, Boelstra TJ1, Haagsma EB2,
van den Berg AP2, TenVergert EM3, Slooff MJH1, (1) Department
of Surgery, Division of Hepatobiliary Surgery and Liver
Transplantation, Groningen; (2) Department of Gastroenterology
and Hepatology, Groningen University Hospital; (3) Office for
Medical Technology Assessment, Groningen University Hospital,
Groningen, The Netherlands
INTRODUCTION AND AIM: The aim of the study was to assess
predictive factors for actual long-term patient survival in a single-
center cohort of 161 adult liver transplant recipients, transplanted
between March 1979 and December 1992. All patients had com-
pleted a minimum follow-up of 10 years. The influence of donor-,
recipient-, and transplant-related variables on patient survival was
examined. PATIENTS AND METHODS: Prospectively collected
data were retrieved from a database. Univariate analysis was
performed using the chi-squared test, Kaplan-Meier survival analy-
sis, log rank test, and the Mann-Whitney U-test, where appropriate.
Variables from the univariate analysis with a p value 50.1 were
entered in the Cox regression for multivariate analysis. RESULTS:
1-year and 10-year patient survival was 71% and 57%, respectively.
70 patients died (43%); the majority of these patients (67%) died
during the first year post-LT. Patients who survived 1-year post-LT
had an 80% probability of surviving 10 years. After multivariate
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analysis, per-operative blood loss, VVB, and recipient gender
appeared to be significant predictors for both 1-year and 10-year
patient survival. CONCLUSION: This is the first study in which
actual (non-estimated) long-term survival figures post-LT are
presented. Survival of the first year is an important predictor for
10-year survival. The fact that per-operative blood loss and VVB are
significant determinants for both short- and long-term survival
implies that surgical technique is the key predictor for survival post-
LT. This study further suggests that survival analysis of this
population may be performed with a relatively short on1-year actual
follow-up.
14 WHEN DOES A COMPLEX BILE DUCT INJURY GO
SO FAR AS TO NEED A LIVER TRANSPLANTATION?
de Santiban˜es E, Pekolj J, Quin˜onez E, Palavecino M, Ciardullo M,
Mattera J, Hepato-Pancreato-Biliary Surgery and Liver
Transplantation, Hospital Italiano, Buenos Aires, Argentina
INTRODUCTION AND AIM: Complex bile duct injuries (BDI)
represent the most severe complication after a biliary surgery. After
multiple surgeries and palliative procedures, some patients can
develop a progressive liver failure because of secondary biliary
cirrhosis and portal hypertension. The aim of this study is to evaluate
our experience in liver transplantation (LT) as a treatment of BDI.
PATIENTS AND METHODS: Between January 1989 and
December 2003 we treated 166 patients with BDI. Eighteen were
included in the waiting list for LT. Mean age was 41 years (r: 24–62).
The lesions were inflicted during cholecystectomies (7 open and 3
laparoscopic). Mean interval between BDI and inclusion in the
waiting list was 41.8 months (r: 14–76). The indications for LT were
failed previous reoperations and palliative procedures, with conse-
quent recurrent cholangitis, digestive hemorrhage for esophageal
varices, intractable pruritus and the deterioration of quality of life
secondary to the liver failure. RESULTS: Thirteen patients were
transplanted, 4 died on the waiting list. Mean stay on the waiting
list was 20.6 months (r: 2–84). Mean operative time was 9.4 h (r: 6–
12.3). In-hospital mortality was 2 (15.3%), 1 because of a
pneumonia and the other for the rupture of an intracranial aneurysm.
One patient was reoperated with a secondary peritonitis and the other
with a hemoperitoneum. Three patients presented minor complica-
tions (2 wound infections, 1 inguinal lymphocele). One patient
required re-transplantation for a late arterial thrombosis and died.
CONCLUSION: LT represents the only curative treatment for
irreversible liver failure secondary to BDI.
15 HANGING MANOUVER FOR HEPATECTOMY IN
LIVING RELATED DONOR – ANATOMICAL
CONSIDERATIONS
Trotovsˇek B, Tomazˇie` A, Sojar V, Stanisavljevie` D, Department of
Abdominal Surgery, University Medical Centre Ljubljana,
Ljubljana, Slovenia
INTRODUCTION AND AIM: During right hepatic resection
mobilization of the right lobe of the liver before parenchymal trans-
ection has been advised. Injudicious mobilization of the liver carries
the risk of excessive bleeding from avulsion of the SRHV and short
veins of segment 9 entering IVC, and poor graft and remnant liver
function as a consequence of prolonged ischemia of the liver from
rotation of the hepatoduodenal ligament. Alternatively the anterior
approach was proposed. Although blood loss and transfusion
requirement was lower in the anterior approach, severe bleeding
during parenchymal dissection could be encountered. This could be
avoided with the recently described liver-hanging maneuver. During
this procedure blind dissection between the IVC and the liver is
performed and short veins, entering the IVC from segments 1 and 9
could be torn. Hemorrhage can occur from the apparently avascular
route on the anterior surface of the IVC. PATIENTS AND
METHODS: We prepared 100 corrosive casts of healthy livers. The
surface of the IVC from entry of the renal veins to hepatic veins was
studied. RESULTS: Venous drainage from segment 1 into IVC is
dominant in 95%. Veins from segment 9 predominantly drain (64%)
into SRHV but in 82% of casts there are veins entering the IVC
directly. The downward dissection between SRHV and MHV is safe
for 25 mm, as no short subhepatic veins were observed. It is
important to dissect at an angle of 0 in the longitudinal axis of IVC,
parallel to its right border, with the point of the angle being the most
medial point of SRHV. The upward blind dissection of the avascular
route should start approximately 10 mm from the right border
toward the already prepared space between SRHV and MHV.
The ligation of segment 1 veins is not obligatory, because those veins
that are always present do not thwart the dissection route.
CONCLUSION: With the dissection along the proposed route the
risk of disrupting the short veins is up to 7%. Results of corrosive cast
studies show that the hanging maneuver is a safe procedure and could
be more readily used in clinical practice.
16 PRESERVATION OF THE STEATOTIC DONOR RAT
LIVER: MACHINE PERFUSION VERSUS COLD STORAGE
Bessems M, Doorschodt B, Kolkert J, van Vliet A, van Gulik T,
Surgical Laboratory, Department of Surgery, Academic Medical
Center, Amsterdam, The Netherlands
INTRODUCTION AND AIM: Approximately 30% of donor livers
are discarded because of steatosis. These livers are suboptimal and
perform weakly when transplanted after cold storage preservation.
Hypothermic machine perfusion (MP) has shown superior preser-
vation for heart-beating and non-heart-beating donor livers as
compared to cold storage (CS). The aim of this study was to compare
CS in University of Wisconsin solution (UW) and MP using
UW-Gluconate for preservation of the steatotic donor rat liver.
PATIENTS AND METHODS: Steatosis was developed in rats
using a choline-methionine-deficient diet. In an isolated perfused rat
liver model hepatocellular damage and liver function were assessed
during reperfusion of a steatotic liver after 24-h hypothermic CS in
UW (n=7) or hypothermic MP using UW-G (n=7). To determine
liver parenchymal damage AST, ALT, LDH levels were measured
during 60 min of normothermic reperfusion with oxygenated Krebs-
Henseleit buffer. Liver function was assessed by measuring bile
production, oxygen consumption, ammonia clearance and urea
production during reperfusion. RESULTS: All animals developed a
30–60% steatosis. Livers preserved by CS released significantly more
liver enzymes as compared to MP at t=30, 45, and 60. Bile
production was significanly lower after CS as compared to MP
(151+32 ı`L versus 238+36 ı`L). Oxygen consumption, ammonia
clearance and urea production also were significantly higher after MP
as compared to CS. CONCLUSION: Hypothermic machine
perfusion ameliorates preservation results of the steatotic rat liver, as
compared to cold storage.
17 THE RESULTS OF USE OF THE EXTRACORPOREAL
VENO-VENOUS BYPASS IN ORTHOTOPIC LIVER
TRANSPLANTATION
Smoter P, Zieniewicz K, Cieœlak B, Skwarek A, Grodzicki M,
Krawczyk M, Department of General, Transplantation and Liver
Surgery, Medical University of Warsaw, Warsaw, Poland
INTRODUCTION AND AIM: Evaluation of the indications and
the results of the treatment of two groups of adult liver transplant
recipients with the use of veno-venous bypass (VVB) in different
periods of the development of the program. PATIENTS AND
METHODS: Clinical records of 100 cases of orthotopic liver
transplantation (OLT) operated on from 1995 to 2004 were
analyzed. Group &#940;50 non-selected patients that underwent
classic OLT in the period when we used only this method at the very
beginning of the program (1995–2001). Group &#946;50 patients
after OLT performed during the 2 last years, selected for VVB for
medical reasons. UNOS score group: 1–2; 2a-7; 2b-29; 3–12, group:
1–3; 2a-10; 2b-23; 4–14. Child score: A-20; B-52; C-28. RESULTS:
For the two groups, overall perioperative mortality was 21.7%,
23.1%, morbidity 27%, 34%; average time of hospitalization: 20, 23
days; minimal body temperature 35.5C, 35.1C; differences not
significant; cardiac output: 7.3, 7.7 [L/min], respectively.
CONCLUSION: The use of VVB does not increase mortality,
morbidity or hospitalization time. Differences in measured para-
meters were not statistically significant in the two groups. The lower
cost of the piggy-back technique suggests that it should be applied as
often as possible, but in some medical cases the use of VVB seems to
be vital. Proper qualification for VVB gives the patients similar
hemodynamic stability in both analyzed groups.
18 THE INCLUSION OF THE MIDDLE HEPATIC VEIN
IN PARTIAL LIVER GRAFT
Ribeiro MAF Jr, Padilha J, Copstein JL, Peron G, Serpa F, Liver
Surgery, Hospital Beneficiencia Portuguesa, Sa˜o Paulo, Brazil
INTRODUCTION AND AIM: In Brazil, the performance of living
related liver transplantation (LRLT) has increased in the last few
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years due to the insufficient number of organ donors as well as the
exponential increase in the number of patients on the waiting list.
Nearly 25% of the liver transplant cases performed are LRLT, with a
stimative of 250 cases to be done by the end of 2004. We report our
experience with the use of right lobes of the liver with the inclusion of
the middle hepatic vein (IMHV). Besides all hemodynamic and
technical considerations, the results of this procedure are related
to the size of the grafts and its drainage. PATIENTS AND
METHODS: In our series we report the use of the MHV in 8 partial
liver donors in a total number of 37 LRLT. In all cases the evaluation
before donation included complete biochemical, sorological and
tumoral marker evaluation, imaging studies included ultrasound and
multi-sliced CT with vascular, biliary reconstruction and hepatic
volumetry. Cardiac, pulmonary, renal and psychological evaluation
were performed routinely before donation. During the donor surgery
the surgeons performed intraoperative ultrasound to confirm the
vascular anatomy of the hepatic veins, and cholangiography. Based
on its anatomy, the aspect of the vascular outflow and the size of the
remnant left size of the liver, we performed a right lobe hepatectomy
including the MHV. RESULTS: The mean operative time was
420 min, the mean weight of the graft stimated by CT volumetry was
860 g and soon after harvesting 785 g. The mean blood loss was
310 ml and the cell saver was used in all cases, the 300 ml of auto-
logous blood saved in the preoperative period was also used. There
was no mortality in this current series, and the complications to the
donors were: intraoperative complications (none); until 7th POD we
had 2 biliary fistulas (one treated by papillotomy and another
resolved spontaneously) and one case of ascites. No long-term
complications so far. The recipients presented good graft function in
6 cases, the liver function tests were within normal range after 10 days
and the complications related to the graft were as follows: 2 cases of
arterial complications (one death before re-transplant and another
submitted to new transplant and alive); 1 case of biliary complication
resolved by percutaneous drainage; 4 other complications, 1 liver
disfunction with jaundice, 1 recurrence of tumor, 1 bleeding on the
cutting surface and 1 case of refractory ascites. The overall graft
survival is 75% (6 of 8). CONCLUSION: The use of the MHV is
feasible and safe, its use can improve the venous outflow, providing a
gain in the hepatic ‘functional’ mass of the graft and in consequence
its faster recovery from surgery.
19 SMALL HEPATOCELLULAR CARCINOMA IN
CIRRHOTIC CHILD A PATIENTS: RESECTION OR LIVER
TRANSPLANT?
Del Gaudio M, Grazi GL, Ercolani G, Zanello M, Cescon M,
Varotti G, Ravaioli M, Vetrone G, Lauro A, De Ruvo N, Pinna AD,
Liver and Multiorgan Transplantation, University of Bologna,
Bologna, Italy
INTRODUCTION AND AIM: Nowadays, it is still debated
whether hepatic resection (HR) or liver transplantation (LT) is the
best strategy for patients with Child A cirrhosis and small hepato-
cellular carcinoma (HCC). PATIENTS AND METHODS: We
analyzed retrospectively 146 Child A patients with single HCC
55 cm; 19 who underwent LT (Group 1) were compared to 127
who underwent HR (Group 2). RESULTS: No differences regarding
sex, cirrhosis etiology, follow-up; age was higher in Group 2 (63.4
9+8.42 vs 50.16+5.76, p50.0001). Tumor size was bigger in
Group 2 (33.30 mm+11.44 mm vs 26.74+10.24, p=0.02), alfa--
fetoprotein was lower in Group 1 (52.80+133.85 vs 228.64+
754.35), chemoembolization was more frequent in Group 1 (73.7%
vs 37.8%, p=0.003). Higher incidence of pT2 in Group 2 (44.1%
vs 26.3%, p=0.001) and of pT1 in Group 1 (36.8% vs 7.1,
p=0.001). Grading was mainly G1 (31.6% vs 6.3%, p=0.002) and
G2 (47.4% vs 33.9%, p=0.002) in Group 1 and G3 (48% vs 21.1%,
p=0.002) in Group 2. Postoperative mortality was 0% vs 3.1%
respectively in Group 1 and 2 (p=ns), morbidity was higher in Group
1 (52.6% vs 32.3%, p50.0001). Hospitalization was longer in
Group 1 (22.11+12.42 vs 15.98+10.95, p=0.02). HCC recur-
rence was higher in Group 2 (29.9% vs 10.5%, p50.0001). No
statistically difference in 1-, 3- and 5-year overall (94%, 89%, 82% vs
92%, 80%, 77%, p=ns) and disease-free (94%, 88%, 88% vs 88%,
73%, 66%, p=ns) survival in Group 1 and 2, respectively.
CONCLUSION: HR vs LT are comparable in Child’s A patients
with HCC55 cm.
20 SEQUENTIAL TRANSARTERIAL
CHEMOEMBOLIZATION (TACE) FOLLOWED BY
ORTHOTOPIC LIVER TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA BEYOND THE
MILAN CRITERIA
Moench C1, Grebe A1, Meier S2, Herber S2, Pitton M2,
Schuchmann M3, Otto G1, (1) Transplantation Surgery;
(2) Radiology; (3) Internal Medicine, Johannes Gutenberg
University Mainz, Mainz, Germany
INTRODUCTION AND AIM: Orthotopic liver transplantation
(OLT) is a standard indication for curative treatment of small
hepatocellular carcinoma (HCC) fulfilling the Milan criteria (MC).
So far bridging treatment during waiting time is not standardized.
PATIENTS AND METHODS: Patients with histologically proven
HCC and no contraindication for OLT (extrahepatic tumor,
comorbidity, age, compliance) entered this study without restriction
because of MC. Bridging until OLT was performed with sequential
TACE (lipiodol, mitomycin C) at strict intervals of 6 weeks. After 4
cycles restaging was performed: patients responding to TACE (stable
disease/down-staging) were put on the waiting list and transplanted
(TG). TACE went on until OLT. Patients without response to
TACE (tumor growth, distant metastasis) were treated palliatively.
Patients with known HCC treated outside the protocol before OLT
or with an incidentally detected HCC in the postoperative histology
after OLT served as control group (CG). RESULTS: Between 09/
1997 and 01/2004 34 patients entered the study (age 57+/76 years,
MC fulfilled n=15), 30 patients were in CG (age 54+/78 years, MC
fulfilled n=18). 5 patients in CG experienced recurrent HCC and
died. In TG two patients out of three with tumor recurrence died.
The three patients with recurrence after OLT all showed tumor
progress during TACE. Tumor-free 6-year survival was 83% and
23% in TG and CG, respectively (p=0.0038). 6-year patient survival
was 93% and 23% in TG and CG, respectively (p=0.0005).
CONCLUSION: In this trial recurrence of HCC following OLT was
dependent on a strict pretreatment with TACE which had a signifi-
cant influence on tumor-free survival. We saw no recurrence in
patients with response to TACE. MC did not have any influence.
21 DONOR SAFETY AND LONG-TERM OUTCOME IN
ADULT LIVING DONOR LIVER TRANSPLANTATION
Kim DG, Lee KH, Lee MD, Department of Surgery, Catholic
University of Korea, Seoul, Korea
INTRODUCTION AND AIM: This study is to review our donor
hepatectomy experience in living donor liver transplantation
(LDLT) using the right lobe, specifically in the context of preserving
donor safety. PATIENTS AND METHODS: From October 2000
to December 2001, 128 donor operations for adult LDLT using the
right lobe were performed. We reviewed donor characteristics,
operative findings, and postoperative results, including the peak
value of liver enzymes (AST, ALT, and bilirubin) and regeneration
activity, as evaluated by CT volumetry at 3 months postoperatively.
RESULTS: Total volume of the donor liver ranged from 926 to
2838 ml (mean 1398 ml), leaving from 288 to 1025 ml (mean
512 ml). According to remnant lest liver volume, there was a statis-
tically significant difference between the group with530% and the
group430% in postoperative liver enzymes (p50.05), but there was
no significant difference among the groups with 430%. The mean
regeneration of the remnant left lobe at 3 months postoperatively was
209 ¡3/4 51% and the group with 535% of remnant liver volume
showed more regenerative activity than the group with435%. The
patients were hospitalized from 9 to 27 days after operation (mean
13.5 days). There was no donor mortality but postoperative
complications were observed in 41 patients (41/128, 32.0%).
CONCLUSION: Right lobectomy can be performed safely with
minimal risk in cases of careful donor selection such that the remnant
liver volume exceeds 30% of the total liver volume while showing
minimal fatty change.
22 LIVER TRANSPLANTATION IN SLOVENIA
Stanisavljeviæ D, Ljubljana, Slovenia
INTRODUCTION AND AIM: Liver transplantation is an
estabished method of treatment of liver fealure. The first liver
transplantation in Slovenia was in 1995. A donor program started in
1998 and until now we have performed 65 liver transplantations.
PATIENTS AND METHODS: Liver transplantation is the most
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demanding of solid organ transplantations. It demands perfect
organization of services and motivation of health care professionals,
patients and their families. Slovenia is over Sloveniatransplant
member of Eurotransplant. We have 1 transplantation center and 9
donor hospitals—regional hospitals with 14 donors per million
inhabitants yearly. All candidates are prepared in the University
Centre Ljubljana under the guidance of 4 hepatologists, 2 liver
surgeons, 2 anesthesiologists, 1 intensivist and 2 nurse coordinators.
RESULTS: From October 1998 until October 2004, 65 liver
transplantations in 61 patients were performed, in 4 patients
retransplantation was necessary. 1-year and 3-year survival of
patients after liver transplantation is 80%. CONCLUSION: The
number of liver transplantations in Slovenia is too low according to
the national pathology of liver diseases.
23 A NEW ERA OF PEDIATRIC LIVER
TRANSPLANTATION
Kim JS1, Mueller T1, Grotelueschen R1, Fischer L1, Ganschow R2,
Helmke K2, Burdelski M2, Rogiers XV1, Broering D1,
(1) Department of Hepatobiliary Surgery and Multiorgan
Transplantation; (2) Department of Pediatrics, University Hospital
Eppendorf, Hamburg, Germany
INTRODUCTION AND AIM: Between May 2001 and September
2004, 170 consecutive pediatric OLTs were performed at our center
without hospital mortality. However, higher patient survival was not
sustained by higher graft survival. Analysing our series, graft survival
after reduced-size liver transplantation showed a significantly lower
rate versus living donor liver transplantation. PATIENTS AND
METHODS: From May 2001 until September 2004, 22 whole
organs (13%), 18 reduced-size (11%), 79 split organs (47%) and 51
organs from living donors (30%) were transplanted into 142 patients.
141 were primary, 25 secondary, 3 third and 1 fourth liver trans-
plants. 18% of the pediatric patients were on a high urgency status.
RESULTS: After 170 consecutive pediatric liver transplantations
using all techniques no patient died during the hospital course (100%
patient survival53 months) and overall five recipients (2.9%) died
during further follow-up. The 3-month and actual graft survivals are
93% and 85%, respectively. 20 children (11.8%) had to undergo
retransplantation. Biliary complication rate was 7%; arterial
complications occurred in 7%; intestinal perforation was observed in
3.5%; and in 4.7% postoperative bleeding required reoperation.
Portal vein complication rate was 1.8%. 8 patients (4.7%) developed
chronic rejection in the further follow-up. CONCLUSION: The
learning curve in pediatric liver transplantation has reached a turning
point where immediate patient survival is considered the rule. It is a
challenge to uplift the graft survival to the same level in order to
achieve optimal quality of life for the pediatric recipients.
24 BILIARY COMPLICATIONS AND MANAGEMENT
IN PEDIATRIC LIVER TRANSPLANTATIONS: ONE
CENTER’S EXPERIENCE
Karakayali H1, Haberal MA4, Sevmis S1, Dalgic A1, O¨zc¸ay F2,
Aytekin C3, Noyan T1, Haberal M1, (1) General Surgery Division of
Transplantation; (2) Paediatri; (3) Radiology; (4) General Surgery,
Baskent University Faculty of Medicine, Ankara, Turkey
INTRODUCTION AND AIM: Biliary complication rates are
reported to be between 15% and 30% following liver transplantation,
with biliary complication rates being more prevalent in pediatric
patients (518 years old). Biliary complication data from 21 pediatric
patients who had liver transplants between September 2001 and June
2004 were retrospectively studied. PATIENTS AND METHODS:
The mean age of patients was 8.3+5.05 years (range, 1–18 years).
Sixteen patients (76.2%) were male and 5 were female (13.8%).
Grafts had been donated from mothers (n=10), fathers (n=6),
cadaver (n=1), brother (n=1), grandfather (n=1), and uncles
(n=2). The left lobe was transplanted in 57.1% (n=12), the left
lateral segment in 33.3% (n=7), and the right lobe in 9.6% (n=2) of
patients. Biliary reconstruction was accomplished via a duct-to-duct
anastomosis in 12 (57.2%) patients and via a Roux-en-Y hepatico-
jejunostomy in 9 (42.8%). RESULTS: A biliary stent traversing
through the anastomosis was placed during the operation and
removed at the end of the third postoperative week after a control
cholangiography. Postoperative biliary complications were encoun-
tered in 8 (38.1%) patients. Of these, 1 patient (4.7%) had anasto-
motic stenosis and 7 (33.3%) had biliary leakage. Four of the biliary
leaks were from the duct-to-duct anastomoses. One patient also had
hepatic arterial stenosis. All of the patients with biliary leakage were
treated with percutaneous drainage catheters. An endoluminal biliary
stent was placed in one patient percutaneously. Mean follow-up time
was 10.2+9.6 (range, 1–26) months. Three patients died during
follow-up. Mortality due to biliary complications was not encoun-
tered. CONCLUSION: Interventional radiologic measures includ-
ing cholangiography are highly effective in the treatment of biliary
complications, even in the face of heavily disrupted anastomosis.
In cases of biliary complication, percutaneous drainage, combined
with internal drainage, may prevent biliary sepsis and provide long-
term patency.
25 EXPANSION OF THE TUMOR SIZE IMPAIRS
OUTCOME AFTER LIVER TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA
Loehe F2, Lo¨hrs U1, Angele M2, Jauch KW2, Schauer R2, (1)
Institute for Pathology, Ludwig-Maximilians-University, Munich,
Germany; (2) Department of Surgery, Ludwig-Maximilians-
University, Klinikum Grosshadern, Munich, Germany
INTRODUCTION AND AIM: Many centers apply the Milan
Criteria (solitary tumor 55 cm or 53 cm for max. 3 nodules) to
select patients with a hepatocellular carcinoma (HCC) for orthotopic
liver transplantation (OLT). Recently, there has been a tendency
to expand tumor sizes qualifying for OLT. The present study re-
evaluates tumor size and histopathological features as selection
criteria for OLT. PATIENTS AND METHODS: 93 adult HCC
patients underwent OLT between June 1985 and December 2003 at
our institution. Median follow-up was 28 months (1–222 months).
76 patients had a preoperatively diagnosed HCC. In 17 cases a HCC
was detected on the explanted liver. The Milan criteria were routinely
applied since 1994. RESULTS: In general, 5-year survival rate of
HCC patients was significantly lower than in patients transplanted
for benign diseases, 41% and 71% respectively (p50.0001). Multi-
variate analysis revealed that the presence of vascular invasion re-
presents the most significant predictor (p50.001)affecting the overall
survival rate. Nonetheless, survival was also significantly impaired
when the tumor size was45 cm (p50.05), whereas the number of
nodules had no significant effect on survival. Consequently, the
survival rate for HCC fulfilling the Milan criteria was 60% at 5 years
and even improved to 70% since 1994. CONCLUSION: Tumor size
has been shown to be the most important preoperatively detectable
predictor for patient survival after OLT.
26 LIVER RETRANSPLANTATION: RESULTS OF
A SINGLE CENTER IN ARGENTINA
Barros Schelotto P, Lendoire J, Duek F, Quarin C, Garay V,
Braslavsky G, Cejas N, Trigo P, Imventarza O, Liver
Transplantation, Hospital Dr Cosme Argerich, Buenos
Aires, Argentina
INTRODUCTION AND AIM: Liver retransplantation (re-OLT)
provides the only life-saving procedure for liver transplant recipients
in whom an existing graft has failed. The incidence of re-OLT varies
between 5 and 20%. Long-term survival is 10–30% lower than the
first transplant. The aim of this study was to review and to analyze the
results of re-OLT. PATIENTS AND METHODS: Between July
1995 and May 2004, 269 liver transplantations were performed in
244 patients. 25 re-OLT in 23 patients (9.3%) were analyzed: 23
patients recieved a second transplant and in two oportunities a third
one. Mean age was 34 (18–62) and male gender 44%. Main indi-
cations for re-OLT were: hepatic artery thrombosis (60%) and
chronic rejection (16%). The average period for the first transplan-
tation to the re-OLT was 217 days (12–2068). Effect of recipient,
donor and operative variables at time of transplantation or re-OLT
were reviewed. A comparative analysis was made with 244 patients
who received a first transplantation. RESULTS: There were no
statistical differences in demographic variables, blood transfusion,
biliary and arterial complications. In retransplant patients, statistical
differences were found in the utilization of arterial graft (p=0.0001),
incidence of reoperation (p=0.0001), reoperation with hemoper-
itoneum (p=0.001) and 30 days mortality (p=0.05). Retransplant
patients survival rate at 1 year was 67% compared to 76% in a series
of 244 first transplants (p=ns). CONCLUSION: Our results suggest
that re-OLT presents a high incidence of early morbi-mortality
without an increase in surgical complications nor an influence on late
survival.
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27 NO CORRELATION BETWEEN PLASMA
DISAPPEARANCE RATE (PDR) OF INDOCYANINE GREEN
(ICG), FACTOR V AND BILIRUBIN EARLY AFTER
ORTHOTOPIC LIVER TRANSPLANTATION
Swol-Ben JB1, Obed A1, Scherer MN1, Bro¨ckner S1, Schlitt HJ1,
Bein T2, (1) Department of Surgery, University of Regensburg;
(2) Department of Anaesthesiology, University of Regensburg,
Regensburg, Germany
INTRODUCTION AND AIM: Plasma disappearance rate (PDR)
of indocyanine green (ICG) has been proposed as a prognostic factor
in critically ill patients, in patients with chronic liver failure and for
evaluation of liver function in liver transplants donors and recipients.
The aim of the study was to assess the correlation between PDR,
factor V and bilirubin early after orthotopic liver transplantation.
PATIENTS AND METHODS: The PDR of ICG using a non-
invasive digital pulse densitometry method (Limon Pulsion Medical
Systems, Munich, Germany) was measured in 10 patients (3 female,
7 male) in the early postoperative period after OLT. Indications for
OLT were alcoholic liver disease (n=3), chronic active hepatitis
(n=3), hepatocellular carcinoma complicating hepatitis B cirrhosis
(n=1), autoimmune hepatitis (n=1), primary sclerosis cholan-
gitis (n=1), liver failure after trauma (n=1). A finger-piece sensor
was used for non-invasive pulse densitometric PDR-ICG assessment.
0.5 mg/kg of ICG in cooled saline (10–15 ml) was injected through a
central venous catheter. RESULTS: PDR-ICG (%/min) ranged
from 5.7 to 41 (mean 10.8 SD+/710.1). Factor V (%) ranged from
12 to 56 (mean 43 SD +/713.7). Bilirubin (mg/dl) ranged from
2.53 to 22.3 (mean 5.4 SD+/75.7). Pearson correlations between
PDR and factor V (r=0.213, p=0.55) as well as between PDR and
bilirubin (r=0.189, p=0.60) are not significant. CONCLUSION:
There is no correlation between ICG-PDR, factor V and bilirubin as
indicators for early graft function after liver transplantation, although
each of these parameters per se has been found to be of prognostic
value. Further studies should include a “multimodal” monitoring for
assesssment of liver function early after transplantation.
28 TECHNICAL VARIATION IN THE USE OF THE
SPLENIC ARTERY TO THE GRAFT ARTERIAL
REVASCULARIZATION IN RETRANSPLANTATION
Ribeiro MAF Jr, D’Albuquerque L, Padilha J, Copstein JL, Peron G,
Serpa F, Casagrande M, Silva A, Liver Surgery and Transplantation,
Hospital Beneficiencia Portuguesa, Sa˜o Paulo, Brazil
INTRODUCTION AND AIM: The most common approach
during the arterial graft revascularization in the liver retransplanta-
tion are either the anastomosis directly in the aorta or the use of the
splenic artery in the celiac trunk. One of the main challenges in this
kind of procedure is the number and intensity of adjacent organ
adherences, especially in the hepatic hilum, lesser gastric curvature
and celiac trunk, making the surgical dissection a hard procedure.
The aim of this report is to present a different and unusual approach
to the splenic artery to the reperfusion of the graft. PATIENTS AND
METHODS: The description of the technique is as follows: opening
of the greater gastric curvature between the stomach and transverse
colon and careful dissection of the splenic artery in the upper
pancreatic border from the head of the pancreas until we obtain an
arterial segment of 5 cm. Then this part of the artery is carefully cut
and then prepared for anastomosis. The splenic artery of the receptor
is passed by a 1-cm hole in the lesser curvature, making the anasto-
mosis with the donor hepatic artery at the level of the celiac trunk in a
conventional end-to-end continuous suture using a 6-0 prolene
suture. RESULTS: We have used this approach in cases of retrans-
plantation and it seems to be an easy and fast way to perform the
reconstruction of the artery avoiding an extensive dissection of the
adherent tissues around the hilum. CONCLUSION: This alter-
native technique is safe, feasible and can be used in cases of
retransplantation.
29 USE OF THE RECEPTOR’S OWN SPLENIC ARTERY
GRAFT TO HEPATIC ARTERY RECONSTRUCTION IN
LIVING DONOR LIVER TRANSPLANTATION
D’Albuquerque L, Ribeiro M Jr, Copstein JL, Serpa F, Padilla J,
Silva A, Liver Surgery and Transplantation, Hospital Beneficiencia
Portuguesa, Sa˜o Paulo, Brazil
INTRODUCTION AND AIM: The receptor arterial reconstruction
in the living donor liver transplantation (LDLT) represents one of the
major problems in this modality of transplant. Besides these technical
difficulties the portal hyperflux due to high portal hypertension also
represents another serious problem in the management of these
patients in the immediate postoperative period. Nowadays there are
an increasing number of papers proposing new insights and solutions
trying to create a rationale in these matters. In patients with portal
hypertension we propose a new approach to solve these two major
problems at the same time, firstly by the dissection and section of the
splenic artery (SA) as near as possible to the celiac trunk in the
receptor, taking a 3–5-cm graft to be anastomosed to the right or left
hepatic artery (HA) at the bench during the back table period. This
approach brings solution of these two problems, as it in turn eases the
complex hepatic arterial anastomoses in the receptor after reperfu-
sion at the surgical receptor operative field and as a consequence
reduction in the portal blood flow to the liver decreasing the hyper-
flux syndrome as the splenic ligature importantly decreases the
splenic blood component to the portal flow. PATIENTS AND
METHODS: We applied this vascular reconstruction technique to
LDLT of the right lobe in three patients. Case 1: a 54-year-old
woman with hepatocellular carcinoma (CHC), hepatitis C and portal
hypertension (HP). Case 2: a 28-year-old male with sclerosing
cholangitis presenting severe acute crisis of cholangitis and present-
ing a huge spleen and HP. Case 3: a 52-year-old male with hepatitis
C, CHC and HP. All donors were first-degree relatives and approved
by the Hospital Ethics Committee. All patients (donors and recep-
tors) had an uneventful evolution being discharged between 1 and 2
weeks. The procedure is done by opening the greater gastric curva-
ture between the stomach and colon, finding the splenic artery at the
upper pancreatic border and then dissecting it for an extension of
5 cm, beginning at the celiac trunk. After sufficient length of splenic
graft is obtained the SA is ligated and resected. This segment is then
offered to the donor surgical team, which performs the anastomoses
between the SA graft and the donor right HA with a 6-0 running
suture with 3.5 magnificent lenses, at the back table. RESULTS:
After the reperfusion the arterial graft HA reconstruction in situ is
much easier to perform as it is exactly the same anastomoses that we
are used to doing in cadaver LT, with a safer distance from the biliary
duct. CONCLUSION: This is a feasible and safe technique for
arterial reconstruction in LRLT, making this anastomosis similar to
the cadaveric one.
30 HEPATOCELLULAR CANCER AS AN INDICATION
FOR LIVER TRANSPLANTATION—INITIAL EXPERIENCE
Zieniewicz K, Patkowski W, Alsharabi A, Michalowicz B, Nyckowski
P, Pawlak J, Paluszkiewicz R, Wroblewski T, Grzelak I, Najnigier B,
Smoter P, Hevelke P, Skwarek A, Paczek L, Krawczyk M,
Department of General, Transplant & Liver Surgery, Medical
University of Warsaw, Warszawa, Poland
INTRODUCTION AND AIM: Liver transplantation (LTx) for
hepatocellular carcinoma (HCC) is currently widely accepted. This
is a retrospective overview of the indications and results of initial
series of LTx in the patients with HCC. PATIENTS AND
METHODS: Among 314 adult liver transplant recipients in the
period 1994–2004, in 16 (5.1%)—11 men and 5 women aged 20–65
(mean 44.6 years), the indication was HCC. It developed in cirrhotic
liver in 15 patients; 9 of them (60%) were Child C, 5 (33.3%) were
Child B and 1 (6.7%) was a Child A patient. The majority of patients
suffered from HBV and/or HCV cirrhosis (9 (60%)—HCV, 3
(20%)—HBV/HCV). Mean MELD score—15.6 (9–25). Milan
criteria were met in 11 patients (68.7%). Mean waiting list time was
3.2 months (1–6). 2 patients underwent liver resection, 1 had TACE
prior to LTx. Rapamycine-based immunosuppression was preferred.
RESULTS: Operative mortality was 0.2 patients required early
relaparotomy for intraperitoneal bleeding. 11 patients (68.75%)
are alive in good general condition, free of the disease. 5 patients died
7–28 months after LTx (mean 16.7) from the recurrence of the
disease. 4 of them did not meet Milan criteria at the time of surgery
and were transplanted as the first cases in our series. Mean overall
survival time is 18 months (range 2–36 months). CONCLUSION:
Liver transplantation is a safe and effective method of treatment of
selected patients with HCC in cirrhotic liver. Further investigations
concerning the indications, timing of transplantation and adjuvant
treatment are necessary.
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31 REDUCTION OF PANCREATIC ISCHEMIA/
REPERFUSION INJURY BY AN ENDOTHELIN A RECEPTOR
ANTAGONIST
Uhlmann D, Lauer H, Serr F, Hauss J, Witzigmann H, 2nd
Department of Surgery, University of Leipzig, Leipzig, Germany
INTRODUCTION AND AIM: Endothelin (ET) contributes to
disturbances of pancreatic microcirculation after warm ischemia/
reperfusion (I/R) by causing vasoconstriction and enhancing leuko-
cyte– and platelet–endothelium interactions. The aim of this study
was to investigate a possible protective role of a selective endothelin A
receptor antagonist (ERA) in this setting. PATIENTS AND
METHODS: In an in vivo model (42 Wistar rats), ischemia of the
pancreas was induced for 60 min under anesthesia with xylazin/
ketanest. Sham operated (s.o.) (I), untreated ischemic (II) and
treatment (III) group with BSF208075 (5 mg/kg bw i.v.) were
investigated. The effect of the ERA in I/R was assessed by in vivo
microscopy 30–90 min after reperfusion (capillary diameter, func-
tional capillary density, leukocyte–endothelium interactions,
platelet–endothelium interactions). RESULTS: In the untreated
group, capillary constriction to 78.4+7.3% of s.o. diameters was
observed. A capillary density of 56.8+9.3% of the s.o. group
(384.8+7.5 1/cm) was measured after reperfusion. In addition, we
found an increased percentage of stagnant leukocytes (182.5+
10.4%) and platelets (163.5+12.3%) in postsinusoidal venules
(p50.05). Administration of the ERA before reperfusion signifi-
cantly reduced I/R injury of the organ. Capillary diameters were
maintained (101.4+3.2%) and capillary density was improved
to 85.3+7.6% of s.o. (p50.05). Leukocyte– (112.1+9.8%) and
platelet–endothelium interactions (110.3+10.6%) in sinusoids and
postsinusoidal venules were reduced (p50.05). According to
improved microcirculation, lipase and amylase values and histolo-
gical tissue damage were reduced in the therapy group (p50.05).
CONCLUSION: Our results provide evidence that the new
therapeutic approach with an ERA is effective in reducing pancreatic
I/R injury.
32 SIROLIMUS IMPROVES MICROCIRCULATION, BUT
IMPAIRS REGENERATION AFTER ISCHEMIA AND
REPERFUSION OF THE PANCREAS
Serr F1, Lauer H1, Armann B1, Dansranjavin T1, Rhein T1,
Uhlmann D1, Tannapfel A2, Witzigmann H1, Hauss J1, (1)
Department of Surgery II, University of Leipzig; (2) Institute of
Pathology, University of Leipzig, Leipzig, Germany
INTRODUCTION AND AIM: Ischemia/reperfusion injury (IRI)
plays an important role in the development of post-transplant graft
pancreatitis. The immunosuppressant Sirolimus (SIR) could
potentially modulate the immune/inflammantory reaction of IRI. In
this study the effects of SIR on pancreatic microcirculation and
regeneration after IRI were investigated. PATIENTS AND
METHODS: Warm ischemia was induced by temporary occlusion of
pancreatic arteries for 90 min. Male Lewis rats were randomized to 3
groups (n=21 each): (1) sham surgery, (2) ischemia+vehicle, (3)
ischemia+SIR. SIR (1.5 mg/kg/d) and vehicle were given i.p. start-
ing on day 3 before surgery. 7 animals out of each group were
examined by intravital microscopy. Another 7 animals were killed on
days 1 and 5 after surgery for assessment of histologic injury,
proliferation (Ki-67) and apoptosis (TUNEL). Blood samples were
analyzed for serum endothelin-1, amylase and lipase levels.
RESULTS: In animals subjected to ischemia, treatment with SIR
significantly reduced serum amylase levels 24 h and lipase levels 48 h
after ischemia. No significant differences in endothelin-1 levels were
observed. Intravital microscopy revealed a significant improvement
of functional capillary density and capillaries diameter in the SIR-
treated group. Additionally leukocyte and platelet adherence were
significantly lowered. Nonetheless these animals showed a higher
histological damage and rate of apoptotic cells on day 5. Ki-67
staining revealed no significant difference. CONCLUSION: In our
model of pancreatic ischemia SIR showed dichotomous effects. In the
early phase of reperfusion SIR seemed to improve microcirculation,
on the other hand SIR compromised regeneration of the ischemic
pancreas.
33 LIVING DONOR VERSUS DECEASED DONOR LIVER
TRANSPLANTATION FOR EARLY UNRESECTABLE
HEPATOCELLULAR CARCINOMA: SAME CRITERIA,
DIFFERENT OUTCOME
Lo CM1, Fan ST1, Liu CL1, Chan SC1, Ng IOL2, Wong J1, (1)
Department of Surgery; (2) Department of Pathology, University of
Hong Kong, Hong Kong, China
INTRODUCTION AND AIM: Hypothetical studies that supported
the role of living donor liver transplantation (LDLT) for early un-
resectable hepatocellular carcinoma (HCC) assumed the same out-
come as deceased donor liver transplantation (DDLT). We tested this
assumption with a clinical study. PATIENTS AND METHODS:
We studied 60 consecutive patients who met the Milan or UCSF
criteria on pretransplant imaging and underwent LDLT (LD group,
n=43) or DDLT (DD group, n=17). RESULTS: Compared to the
DD group, the LD group had fewer incidental tumors or pretrans-
plant transarterial chemoembolization but more salvage transplan-
tation for recurrence. There was a shorter waiting time and lower
graft-weight-to-standard-liver-weight (GW/SLW) ratio. The perio-
perative course was the same in terms of transfusion, morbidity,
mortality and hospital stay. Histopathologic analysis showed similar
tumor size, number, grade, and stage. At a median follow-up of 28
months (range: 4–111), 7 (16%) patients of the LD group and none
(0%) of the DD group recurred. The 1-, and 5-year cumulative
recurrence rate was 9%, and 25%, respectively, for the LD group,
and all 0%, for the DD group (p=0.05). The corresponding patient
survival was 97% and 55%, respectively, for the LD group, and 94%
and 94%, respectively, for the DD group (p=0.279). Apart from
tumor factors including vascular permeation, tumor nodules 43,
and a pathologic stage beyond UCSF criteria, GW/SLW ratio50.6
and salvage transplantation were also risk factors for recurrence.
CONCLUSION: Despite standard selection criteria, patients who
undergo LDLT for early unresectable HCC have different clinical
characteristics and inferior oncologic outcome.
34 EVALUATION OF RECIPIENT OUTCOME
FOLLOWING SPLIT- AND LIVING- RELATED LIVER
TRANSPLANTATION USING FULL RIGHT LOBE GRAFTS
Wilms CC1, Lenk C1, Mueller L1, Kim JS1, Schoenherr S1,
Ganschow R2, Burdelski M2, Helmke K3, Rogiers X1, Broering D1,
(1) Department of Hepatobiliary Surgery and Vizeral
Transplantation; (2) Department of Pediatrics; (3) Department of
Radiology, University Hospital Hamburg-Eppendorf, Hamburg,
Germany
INTRODUCTION AND AIM: Due to the worldwide organ
shortage alternative transplantation techniques like full split-liver
transplantation as well as living related liver transplantation have also
become more important for adult recipients. Especially transplan-
tation of right lobe grafts (Seg. V–VIII) harvesting from cadaveric or
living donors is still considered as experimental and even contro-
versial. Therefore the aim of this study is to evaluate the recipient
outcome following split-liver and living related liver transplantation
(LRLT) using a right lobe graft. PATIENTS AND METHODS:
From 1/1999 to 8/2004 a total of 16 FR split-liver transplantations
(right grafts=FR (Seg. V–VIII)) and 32 FR living-related liver
transplantations (right grafts=FR Seg. V–VIII)) were performed in
our centre. The outcome of these 48 adult split-liver or LRLT graft
recipients was prospectively evaluated. A special request was made
for information on patient and graft survival, duration of hospitali-
sation and ICU. Further specific complications like primary
non-function (PNF), primary poor function (PPF), as well as biliary
complications and postoperative bleeding were analysed.
RESULTS: Following LRLT transplantation 4 recipients died
(actual patient survival was 89.7%). In the split-group 2 cases of
death had been deplored (actual patient survival was 84.4%);
Kaplan-Meier, p40.05. In the LRLT group the actual graft survival
was 87.2%, in the split-group it was 76.4%. In each of both groups
one case of PPF was observed. No case of PNF appeared. In the
LRLT group biliary complications, requiring relaparotomy (n=4) or
radiological intervention (n=1), occurred in 5 cases. Following split-
liver transplantation 6 recipients developed biliary complications
(relaparotomy n=4, radiological intervention n=2). Postoperative
bleeding occurred in one case (split-group n=1). Arterial, portal or
venous complications were not observed in either of the groups.
CONCLUSION: Both procedures, full split as well as living-related
54 EHPBA European Congress Abstracts
liver transplantation using the right lobe, has been technically
improved so far allowing excellent results. The major remaining
challenge is the reduction of biliary complications. Both techniques
seem to be good alternatives to the conventional orthotopic liver
transplantation in adulthood. Therefore they are a reasonable
instrument to enlarge the organ pool.
35 ANATOMICAL AND PHYSIOLOGICAL COMPARISON
OF LIVER VOLUMES AMONG THREE FREQUENT TYPES OF
PARENCHYMAL TRANSECTION IN LIVE DONOR LIVER
TRANSPLANTATION
RadtkeA1, Malago M1, Sotiropoulos G1, Paul A1, Lang H1, Frilling
A1, Peitgen H2, Schroeder T3, Broelsch C1, (1) General Surgery and
Transplantation, University Hospital Essen, Essen, Germany; (2)
MeVis-Center for Medical Diagnostic Systems and Visualisation,
University of Bremen, Bremen, Germany; (3) Diagnostic and
Interventional Radiology, University Hospital Essen, Essen,
Germany
INTRODUCTION AND AIM: Adequate venous outflow is a
prerequisite for successful live donor liver transplantation. The aim
was definition and comparison of the anatomical and physiological
characteristics of venous drainage in the three most common types of
liver transection techniques encountered in live donor liver trans-
plantation (Malago, Cantlie, Pringle), which provide different
anatomical approaches. PATIENTS AND METHODS: Volumes of
both graft and remnant livers as well as individual hepatic vein
territories were calculated by means of virtual 3-D reconstruction of
CT images obtained from 55 potential live liver donors using the
software HepaVision. Belonging patterns of the middle hepatic vein
(MHV) were considered on the base of its larger territorial volume on
the right or left hemiliver encountered after each kind of liver parti-
tion was fashioned virtually (n=55) and subsequently confirmed
intraoperatively (n=27). RESULTS: There were no statistically
significant differences in hemiliver volumes among the three types of
liver partition. There was a predominance of MHV belonging to the
right hemiliver: Malago n=45 (82%) vs. Cantlie n=44 (80%) vs
Pringle n=44 (80%). The dominance of the right MHV hemi-
territory showed a mean volume of 284–296 ml, accounting for
59–61% of total MHV volume, revealing little difference among the
three types of liver partition used for comparison. CONCLUSION:
The similarity in the surgical and anatomic-radiological liver parti-
tions found in this study shows reliability of the method. Our findings
allow for underlining the suggestion that improved venous outflow
might be achieved by including the MHV with the right liver graft
without disadvantage to the left liver remnant.
36 PREVALENCE AND COURSE OF BONE DISEASE
IN PATIENTS TRANSPLANTED FOR CHOLESTATIC
CIRRHOSIS
Kadochova J1, Trunecka P1, Kasalicky P4, Lanska V2, Adamec M3,
Spicak J1, (1) Department of Hepatogastroenterology, IKEM; (2)
Department of Statistics, IKEM; (3) Department of Transplantation
Surgery, IKEM, Institute for Clinical and Experimental Medicine
(IKEM), Prague 4, Czech Republic; (4) Department of
Densitometry DC Mediscan, Prague, Czech Republic
INTRODUCTION AND AIM: The aim of the study was to
determine the prevalence, severity and clinical impact of bone disease
in patients transplanted for cholestatic liver cirrhosis, and its course
after transplantation. PATIENTS AND METHODS: From 1995
until 2004, 35 patients with PBC, and 33 with PSC (27 men and 41
women) were transplanted at our center. Median follow-up was 53
months (6–114). Bone density was measured by dual energy X-ray
absorptiometry (DEXA) before and after LTx at 1-year intervals.
Information about fractures was obtained by phone. Results were
evaluated by chi-squared and Wilcoxon test. RESULTS: 115 DEXA
measurements were available for analysis; 97% recipients were
reached by interviewer. Fractures were present in 32 patients in the
pretransplant period, bone disease was found in 82% of patients
(osteoporosis in 44%, and osteopenia in 38%). One year after LTx,
we found osteoporosis in 49%, osteopenia in 43%, at 3 years osteo-
porosis in 21% and osteopenia in 64%. The mean Z-score of bone
before LTx was 712 567, 1 year after LTx 720 116, 3 years
714 522 (p50.002). During the follow-up period, bone density
increased in 31 patients, declined in 15, and no difference was
present in 2 recipients. We recorded bone fractures after LTx in 13 of
66 interviewed patients (18%). CONCLUSION: Bone disease is
highly prevalent (82%) among recipients with cholestatic liver
disease. Bone density further decreases during the first year after
transplantation, and significantly increases later on. Fractures were
less present after transplantation. LTx impacts positively on the
course of bone disease in patients with cholestatic cirrhosis.
37 WASH-OUT OF THE NON-HEART-BEATING DONOR
LIVER: A MATTER OF SOLUTION AND TEMPERATURE?
Bessems M, Doorschodt B, van Vliet A, van Gulik T, Surgical
Laboratory, Department of Surgery, Academic Medical Center,
Amsterdam, The Netherlands
INTRODUCTION AND AIM: Complete wash-out of the non-
heart beating donor (NHBD) liver during harvest is of major
importance for optimal preservation. A new preservation solution for
machine perfusion (MP) was developed, named Polysol. The aim of
this study is to assess Polysol as a wash-out solution for the NHBD
liver and to determine the optimal temperature for wash-out using
Polysol. PATIENTS AND METHODS: Phrenotomy was
performed to obtain circulatory arrest. The liver was washed out with
either UW, HTK or Polysol (different temperatures). After wash-
out, the liver was connected to a reperfusion set-up and was reper-
fused with normothermic, oxygenated Krebs-Henseleit buffer for
60 min, to assess hepatocellular injury and liver function.
RESULTS: Hepatocellular damage was significantly increased in the
UW group, but there were no differences between HTK and Polysol.
Flow was highest after wash-out using Polysol, compared to both
UW and HTK. Bile production was highest after wash-out with
Polysol as compared to HTK and UW. Urea production was
significantly lower after wash-out using UW, as compared to both
HTK and Polysol. In the temperature study, liver damage
was significantly lower at all time points in the 37C group. Bile
production was lowest in the 4C group as compared to both 18C
and 37C. CONCLUSION: Wash-out of the NHBD rat liver with
Polysol results in better reperfusion results as compared to UW and
equal to even better results as compared to HTK. The optimal
temperature for wash-out of NHBD rat livers is 37C.
38 LONG-TERM OUTCOME AFTER RESECTION FOR
SMALL HEPATOCELLULAR CARCINOMA (HCC) IN
PATIENTS WITH HEPATITIS C VIRUS (HCV) INFECTION:
ARGUMENTS FOR A STRATEGY OF RESECTION AS A
BRIDGE TO TRANSPLANTATION RATHER THAN
SALVAGE TRANSPLANTATION
Chirica M2, Durand F1, Sommaca D2, Dondero F2, Paradis V3,
Vella D1, Belghiti J2, (1) Hepatology, Hospital Beaujon; (2) Digestive
Surgery, Hospital Beaujon; (3) Anatomo-Pathology, Hospital
Beaujon, Fontenay-aux-Roses, France
INTRODUCTION AND AIM: Resection followed by salvage liver
transplantation (LT) for recurrence was shown to be a reasonable
option in patients with small HBV-related HCCs. The aim of this
study was to evaluate long-term survival and patterns of recurrence
after resection in patients with HCV-related small HCCs, otherwise
eligible for transplantation with respect to tumor characteristics.
PATIENTS AND METHODS: 47 patients with small HCV-related
HCCs, all meeting the Milan criteria, underwent resection. The
patterns of recurrence were analysed in order to determine if the
patients could still be eligible for salvage LT. Criteria for salvage LT,
i.e. the Milan criteria, were considered to be the same as those for
primary LT. RESULTS: Postoperative morbidity and mortality rates
were 28% and 4%, respectively. Overall 1-, 3- and 5-year survival
after resection was 95%, 63% and 47%, respectively. With a mean
follow-up of 37 months, 23 patients (49%) had recurrence. At the
time of recurrence, 61% were outside the Milan criteria. Only 39%
were eligible for salvage LT. The presence of cirrhosis was signifi-
cantly predictive for non-eligibility for salvage LT. CONCLUSION:
In this series, 5-year survival after resection for small HCV-related
HCC compared poorly with the results reported after LT. The
majority of patients who had recurrence after resection were outside
the Milan criteria at the time of recurrence and no longer eligible
for salvage LT. In this population with HCV infection, resection
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as a bridge to transplantation seems to be safer than resection
followed by salvage transplantation, except perhaps, in those without
cirrhosis.
39 65 LIVE LIVER DONORS: A SINGLE-CENTER
EXPERIENCE
El-Meteini MAS, Fayez A, Fathy M, Abdalaal A, Safaan H, Salah M,
Mokhtar A, Abdalwahab S, El-Dorry A, El-Monayeri MV, Boillot O,
Liver Transplant Unit, Wady El-Neel Hospital, Cairo, Egypt
INTRODUCTION AND AIM: The outcome of live liver donation
(LLD) for end-stage liver disease (ESLD) patients is presented.
PATIENTS AND METHODS: From October 2001 through
October 2004, following informed consent, 71 LLD were contem-
plated, with 6 being aborted. 65 procedures were successfully
completed in 44 males and 21 females with median age 28.9 years.
Body mass index was ¡U¨ 28 and routine liver biopsy was done. Left
liver grafts (LLG) (n=14) included left lateral segment (n=9) or left
liver (n=5). Middle hepatic vein (MHV) inclusion divided right liver
grafts (RLG) (n=51) into RLG+MHV (n=8) or RLG-MHV
(n=43). Peroperative cholangiogram and ultrasound mapping of
MHV and transaction line was performed. Parenchymal transaction
proceeded using harmonic scalpel. Prophylactic heparin was kept for
1 month. RESULTS: Median operative time was 6.3 h while median
blood transfusion was 356 ml. The right bile ducts (RBD) were
single, double or triple in 22, 28 and 1 donor, respectively. In LLG
donors, no morbidity was recorded. In the RLG group, bleeding and
biliary leakage were the main morbidity in 2 (3.9%) and 4 donors
(7.8%), respectively. Re-operation was needed in 4 cases (7.8%), 2
for bleeding control and 2 for biliary leakage where t-tube insertion
and unsuccessful closure of leaking RBD stump were done. The
later case suffered repeated interventions and sepsis and succumbed
on day 67. Median hospital stay was 11.7 days. All donors
returned to their usual activities after 6–10 weeks. CONCLUSION:
LLD is the only hope for ESLD patients in our country. Donor
mortality is unacceptable but with growing experience this will be
abolished.
40 ISCHEMIC PRECONDITIONING REDUCES LIVER
INJURY IN HUMAN LIVER TRANSPLANTATION
Cescon M1, Grazi GK1, Ravaioli M1, Ercolani G1, Vetrone G1,
Varotti G1, Del Gaudio M1, Ballardini G2, Grassi A2, Grigioni WF3,
Pinna AD1, (1) Liver and Multiorgan Transplant Unit;
(2) Department of Internal Medicine, Cardioangiology, Hepatology;
(3) Pathology Unit of the F. Addarii ‘Institute of Oncology’,
University of Bologna, Bologna, Italy
INTRODUCTION AND AIM: The effect of ischemic precondi-
tioning (IP) in human hepatic transplantation is not well defined. We
investigated the mechanisms and effects of IP in primary, isolated
whole liver transplantation (LT). PATIENTS AND METHODS:




reperfusion) was applied to 23 cadaveric donors for LT (Group 1).
Graft function recovery, incidence of PNF, and patient and graft
survivals were compared with 91 LTs using grafts harvested in the
same period from comparable donors (Group 2). In 10 cases in
Group 1 and in 12 cases in Group 2, expression of inducible nitric
oxide synthase (I-NOS) and intercellular adhesion molecule-1
(ICAM-1), hepatocellular proliferation (using MIB-1 monoclonal
antibody), and epithelial apoptosis (using M30 monoclonal anti-
body) were tested by immunohistochemistry in coupled pre-LT and
post-LT liver biopsies. RESULTS: Postoperative peak value of AST
was significantly lower in Group 1 vs Group 2 (p50.05). ALT, total
bilirubin and prothrombin time levels were not different between
groups throughout the first postoperative week. No differences were
found in incidence of PNF and graft and patient survival. I-NOS
was significantly higher post-LT vs pre-LT in Group 2 (p50.004).
The post-LT expression of MIB-1 was lower in Group 1 (p=0.002).
Pre-LT and post-LT expression of ICAM-1 and apoptosis were
not different in both groups. CONCLUSION: IP reduces ische-
mia/reperfusion injury as expressed by post-LT AST and hepato-
cellular proliferation increase. Hepatocellular necrosis and not
apoptosis seems the main mechanism of graft injury. The
beneficial effect of IP seems to be related to the reduction of I-NOS
expression.
41 EARLY RESULTS OF ORTHOTOPIC LIVER
TRANSPLANTATION DEPENDING ON THE TECHNIQUE OF
VENA CAVA INFERIOR ANASTOMOSIS
Zieniewicz K, Remiszewski P, Zieniewicz K, Krawczyk M,
Department of General, Transplantation and Liver Surgery, Medical
School In Warsaw, Warsaw, Poland
INTRODUCTION AND AIM: Estimate of early results of ortho-
topic liver transplantation (OLTx) in adults depending on the
technique of vena cava inferior anastomosis: classic technique and
piggy back technique. PATIENTS AND METHODS: The clinical
records of 100 consecutive patients, who underwent OLTx in 2000–
2003 were analyzed. Group A—50 patients operated with classic
technique OLTx with venovenous extracorporeal by-pass. Group
B–50 patients operated with piggy back technique. The patients who
underwent early retransplantation were excluded from the analysis.
Age of patients in group A: 21–63 years (average=40.3, SD=10.83),
group B: 20–65 years (average=41.4, SD=12.57), gender F/M in
group A: 24/26 and in group B: 28/22. Indications for OLTx were:
acute hepatic failure (6%), chronic liver insufficiency (82%), liver
tumors (5%), metabolic diseases (5%) and Budd-Chiari syndrome
(2%). Degree of liver insufficiency evaluated according to Child
classification: A, 18; B, 52; C, 30 patients and urgency for OLTx on
base of UNOS scale: UNOS 1—group A: 2 patients, group B: 7
patients; UNOS 2a—A: 7, B: 6; UNOS 2b—A: 29, B: 30; UNOS 3—
A: 12, B: 7 patients. RESULTS: Cold ischemic time: group A 270–
960 min (average=523.1; SD=138.07), group B 240–780 min
(average=520.5; SD=128.84). Average results on 10th post-
operative day: AST: group A-76 group B-72; ALT: A-191 B-196;
GGTP: A-376 B-371; ALKP: A-201 B-178; bilirubin: A-6.85 B-
4.74; APPT: A-37.54 B-34.87; PLT: A-176 B-187. Postoperative
complications: 36%in group A, 30%in group B. Mean hospitaliza-
tion time in surgical department: group A, 20; group B, 21days.
CONCLUSION: Early results, morbidity and mortality of both
applied techniques are similar. Hospitalization time is approximately
the same. Individualization in qualifying the patients for given
operative technique is very important. Lower complication rates and
lower cost of treatment in the piggy back technique group suggest in
our experience the advantage of this technique, when compared to
the classical OLTx.
42 LIVING RELATED DONOR LIVER
TRANSPLANTATION: OUR 12-YEAR EXPERIENCE
de Santiban˜es E1, Ciardullo M1, Pekolj J1, Mattera J1, Quin˜onez E1,
Palavecino M1, Sa´nchez Claria´ R1, d
0
Agostino D2, Gadano A3,
(1) Hepato-Pancreato-Biliary Surgery and Liver Transplantation;
(2) Pediatric Gastroenterology; (3) Hepatology, Hospital Italiano,
Buenos Aires, Argentina
INTRODUCTION AND AIM: Liver transplantation is the
standard treatment for end-stage liver disease. Shortage of cadaveric
organs remains a limiting factor for its application. Living donor
grafts have become an option. The aim of this study is to to analyze
the results at the Hospital Italiano de Buenos Aires. PATIENTS
AND METHODS: 476 patients underwent 511 orthotopic liver
transplantations (OLT). Eighty-one patients, 51 children and 30
adults, underwent living donor liver transplantation (LDLT). Donor
evaluation was made through laboratory liver function tests, ultra-
sound, CT scan and angiography. Liver biopsy was performed when
steatosis was suspected. Pediatric patients received segments II and
III (n=46) or monosegmental grafts (n=5). 29 adult patients
received the right liver (RL) and 1 the left one (LL). RESULTS:
Complications were reported in 6 of 51 pediatric donors (11.7%) and
in 6 of 30 (20%) adult donors. The most common indication for
transplantation was biliary atresia in children (65.9%) and hepatitis
C in adults (44%). Vascular complications were found in 8 pediatric
patients (15.6%) and biliary complications in 14 (27.4%). The
actuarial survival rates at 10 years for patients and grafts were 94%
and 90% respectively. Vascular complications were found in 6.89%
of adult patients. Biliary complications occurred in 37%. Patient
and graft survival rates were 89.8% and 89.3%, respectively at 1 year
and 83.7% and 78.4% at 3 years. CONCLUSION: Pediatric living
donor liver transplantation has become an effective option. In adults
this technique presents a higher incidence of complications for the
recipient, and a major risk for the donor.
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43 THE EFFECT OF CARNITINE ON LIPID
PEROXIDATION DURING HEPATIC ISCHEMIA/
REPERFUSION INJURY
Canbaz H1, Akca T1, Caglikulekci M1, Tataroðlu C2, Tamer L3,
Dirlik M1, Kanik A4, Ustunsoy B1, Aydy´y´n S1, (1) General Surgery;
(2) Pathology; (3) Biochemistry; (4) Biostatistic, Mersin University
Medical Faculty
INTRODUCTION AND AIM: Liver ischemia and the following
reperfusion is a process taking place during hepatic resections and
liver transplantation, and associated with liver damage. To investi-
gate the efficacy of exogenous carnitine in protecting liver damage
given at different stages of experimental hepatic ischemia/reperfusion
(IR) procedure in rats. PATIENTS AND METHODS: Animals
were randomly assigned to the following study groups:as sham (SG),
IR (IRG), carnitine given 2 h before IR (C+IRG), just before IR
(CIRG) and just before reperfusion (ICRG). Animals were subjected
to 45 min of ischemia by clamping the hepatic pedicule followed by
30 min of reperfusion before total hepatectomy. L-carnitine
(200 mg/kg) was given intravenously. Malonyldialdehyde (MDA)
and myeloperoxidase (MPO) levels of both serum and liver tissue,
carnitine, total antioxidant capacity (TAOC), ALT and AST of
serum were studied to evaluate IR damage of liver tissue. RESULTS:
There was a significant difference between SG and IRG for all
evaluation parameters; unlike carnitine and TAOC all parameters
were higher in IRG (p50.05). Serum ALT and AST levels of IRG
were significantly higher than the C+IRG, CIRG and ICRG; but
there was not a significant difference between C+IRG, CIRG and
ICRG (p50.05). Serum MDA and MPO levels of IRG were higher
than the carnitine groups; but there was no difference between these
groups. Liver MDA generation of IRG was higher higher than
carnitine groups; C+IRG and CIRG were similar and lower than
ICRG as well. Liver MPO activity of IRG was higher than carnitine
groups; CIRG and ICRG were similar and higher than C+IRG.
TAOC of IRG was lower than C+IRG and CIRG but similar to
ICRG; CIRG and ICRG was similar.TAOC of C+IRG was higher
than all other groups. Serum carnitine level of IRG was lower than
CIRG and ICRG but similar to C+IRG. Serum carnitine level of
ICRG was higher than all other groups; C+IRG and Cy´rg were
similar. CONCLUSION: L-Carnitine given exogenously has a
protective effect in liver tissue against I/R damage by increasing
TAOC, and decreasing lipid peroxidation and polymorphonuclear
neutrophil sequestration. L-Carnitine given 2 h before ischemia
increases the TAOC and decreases liver MPO activity much more
than when given just before ischemia or reperfusion. Carnitine given
before ischemia decreases liver MDA generation much more than
when given before reperfusion.
44 CONFOCAL LASER-SCANNING MICROSCOPY
ANALYSIS OF IN VIVO FORMED HETEROTOPIC LIVER
NEO-TISSUE AFTER MATRIX-BASED HEPATOCYTE
TRANSPLANTATION
Luetgehetmann M3, Paku S1, To¨ro¨k E2, Dandri M3, Petersen J3,
Nagy P4, Ma P5, Rogiers X2, Pollok J2, (1) Joint Research
Organisation, Semmelweis University Budapest, Budapest,
Hungary; (2) Hepatobiliary Surgery, University-Hospital Hamburg
Eppendorf; Hamburg, Germany; (3) Internal Medicine, University-
Hospital Hamburg Eppendorf, Hamburg, Germany; (4) First
Department of Pathology and Experimental Cancer Research,
Semmelweis University Budapest, Budapest, Hungary;
(5) Biomaterials, University of Michigan, Michigan, USA
INTRODUCTION AND AIM: In previous studies we could
demonstrate that matrix-based hepatocyte transplantation leads to
heterotopic liver neo-tissue with strong proliferative activity, with the
formation of bile canaliculi, positive for glycogen, CK18 and Hepar
1. We were now interested in detail in its cell polarity and function.
PATIENTS AND METHODS: PLLA polymers were seeded with
primary rat hepatocytes, pre-cultured in a flow-bioreactor and
transplanted for 1, 4, 12 and 24 weeks. Confocal microscopy was
performed using primary antibodies for pan-cytokeratin, actin,
laminin, HNF-4a, a1-integrin, CD26, connexin 32, claudin, b-
catenin. RESULTS: Laminin-staining showed multiple new blood
vessels within and around the heterotopic liver tissue, negative for the
sinusoidal endothelial marker a1-integrin. The cell areas were
surrounded by a newly formed thin laminin membrane. Cytokeratin
and actin staining displayed a liver-like cytoskeleton. The hepatocyte
polarity marker CD26 und b-catenin showed liver typical distribu-
tion. The hepatocytes were negative for HNF-4a, connexin 32, and
claudin. CONCLUSION: The liver neo-tissue increases in size and
is nourished by multiple newly formed small blood vessels. The cells
display, next to previously found specific markers, positive signals for
liver typical cytoskeleton by cytokeratin and actin staining, and liver-
specific polarity by CD26 and b-catenin. Negativity for claudin may
be a sign for immature formation of tight junctions. Negativity for
HNF-4a and connexin 32 could be attributed to the heterotopic
location. Possible explanations are the maintained high proliferative
activity, or a process of retro-differentiation, since the hepatocytes,
like their progenitor cells (oval cells), are surrounded by a newly
formed laminin membrane.
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